IZEA director granted 4,274 restricted shares

GARDNER LINDSAY A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

GARDNER LINDSAY A reported acquisition or exercise transactions in this Form 4 filing.

IZEA Worldwide, Inc. director Lindsay A. Gardner received a grant of 4,274 shares of restricted common stock as Q1 2026 director fees. The award was valued at $15,000, based on a closing market price of $3.5100 per share on the grant date of March 31, 2026, and vested immediately. Following this compensation grant, Gardner directly holds 131,284 shares of IZEA common stock.

Insider Trade Summary 10b5-1

Grant/Award: 4,274 shares

Grant/Award 1 txn

Insider GARDNER LINDSAY A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,274	$0.00	$0.00

Holdings After Transaction: Common Stock — 131,284 shares (Direct)

Footnotes (1)

1. F1. Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.

Key Figures

Restricted shares granted: 4,274 shares Award value: $15,000 Reference share price: $3.5100 per share +3 more

6 metrics

Restricted shares granted 4,274 shares Q1 2026 director fees stock award

Award value $15,000 Value of restricted stock grant for Q1 2026 director fees

Reference share price $3.5100 per share Closing market price on March 31, 2026 used for valuation

Shares after transaction 131,284 shares Total IZEA common shares directly held by Gardner after grant

Transaction price per share $0.0000 Indicates compensation grant, not a cash purchase

Grant date March 31, 2026 Date restricted stock award was granted and vested

Key Terms

Restricted Stock, director fees, grant date, vests immediately

4 terms

Restricted Stock financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

director fees financial

"Restricted Stock received for Q1 2026 director fees valued at $15,000"

grant date financial

"based on the closing market price of $3.5100 on the grant date of March 31, 2026"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

vests immediately financial

"Award vests immediately at the grant date."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IZEA (IZEA) director Lindsay A. Gardner report in this Form 4?

Lindsay A. Gardner reported receiving 4,274 shares of restricted common stock as Q1 2026 director fees. The award was valued at $15,000, based on a $3.5100 per share closing price on March 31, 2026, and vested immediately at grant.

Was the IZEA (IZEA) Form 4 transaction an open-market purchase or a stock grant?

The Form 4 shows a stock grant, not an open-market purchase. Gardner received 4,274 restricted shares as a compensation award for Q1 2026 director fees, valued at $15,000, with no cash paid per share and immediate vesting at the grant date.

How many IZEA (IZEA) shares does Lindsay A. Gardner hold after this Form 4 transaction?

After the reported transaction, Lindsay A. Gardner directly holds 131,284 shares of IZEA common stock. This total includes the 4,274 restricted shares granted for Q1 2026 director fees that vested immediately on March 31, 2026, according to the filing details.

What was the valuation basis for the IZEA (IZEA) restricted stock grant to Lindsay A. Gardner?

The restricted stock grant was valued at $15,000, using a closing market price of $3.5100 per share on March 31, 2026. That price multiplied by 4,274 shares determined the value of Gardner’s Q1 2026 director fee award in stock.

Does the IZEA (IZEA) Form 4 indicate any vesting schedule for the director stock award?

Yes. The footnote states the restricted stock award vests immediately at the grant date. This means the 4,274 shares issued to Lindsay A. Gardner for Q1 2026 director fees became fully vested on March 31, 2026, without any further service requirement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARDNER LINDSAY A

(Last) (First) (Middle)

1317 EDGEWATER DR #1880

(Street)

ORLANDO FLORIDA 32804

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IZEA Worldwide, Inc. [ IZEA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/31/2026		A		4,274(1)	A	$0	131,284	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock received for Q1 2026 director fees valued at $15,000 based on the closing market price of $3.5100 on the grant date of March 31, 2026. Award vests immediately at the grant date.

Remarks:

	By: /s/ Peter J. Biere as attorney-in-fact for Lindsay A. Gardner	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)